Endocardial fractionation mapping in atrial fibrillation

Endocardial fractionation mapping in atrial fibrillation - EndoMap_1

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON29711

Enrollment

Registered

2006-07-18

Start date

2006-08-14

Completion date

Unknown

Last updated

2024-06-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

atrial fibrillation

Interventions

None listed

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Paroxysmal or persistent AF Structurally normal heart accepted for catheterablation of atrial fibrillation

Exclusion criteria

Exclusion criteria: age >75 years or

Design outcomes

Primary

Measure	Time frame
1) Return of AF on routine holterscan, control surface ECG or holterscan or ECG during complaints. Blinded period 0 to 3 months after ablation 2) Restart of anti arithmic drugs because of atrial arrhythmia, consisting of AF, atrial flutter or atrial tachycardia.	—

Countries

Netherlands

Outcome results